ES554021A0 - Un procedimiento para la preparacion de derivados de tetrahidronaftaleno. - Google Patents

Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.

Info

Publication number
ES554021A0
ES554021A0 ES554021A ES554021A ES554021A0 ES 554021 A0 ES554021 A0 ES 554021A0 ES 554021 A ES554021 A ES 554021A ES 554021 A ES554021 A ES 554021A ES 554021 A0 ES554021 A0 ES 554021A0
Authority
ES
Spain
Prior art keywords
formula
compounds
derivatives
tetrahidronaftaleno
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES554021A
Other languages
English (en)
Other versions
ES8801174A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of ES554021A0 publication Critical patent/ES554021A0/es
Publication of ES8801174A1 publication Critical patent/ES8801174A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/03—Monoamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ES554021A 1984-10-11 1986-04-16 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno. Expired ES8801174A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH487084 1984-10-11

Publications (2)

Publication Number Publication Date
ES554021A0 true ES554021A0 (es) 1987-12-16
ES8801174A1 ES8801174A1 (es) 1987-12-16

Family

ID=4283985

Family Applications (3)

Application Number Title Priority Date Filing Date
ES547756A Expired ES8701145A1 (es) 1984-10-11 1985-10-10 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES554021A Expired ES8801174A1 (es) 1984-10-11 1986-04-16 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES554020A Expired ES8802359A1 (es) 1984-10-11 1986-04-16 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
ES547756A Expired ES8701145A1 (es) 1984-10-11 1985-10-10 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES554020A Expired ES8802359A1 (es) 1984-10-11 1986-04-16 Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.

Country Status (21)

Country Link
US (1) US4680310A (es)
EP (1) EP0177960B1 (es)
JP (1) JPS6191157A (es)
KR (1) KR860003200A (es)
CN (1) CN1007727B (es)
AT (1) ATE61791T1 (es)
AU (1) AU589375B2 (es)
CA (1) CA1287636C (es)
DE (1) DE3582217D1 (es)
DK (1) DK464885A (es)
ES (3) ES8701145A1 (es)
FI (1) FI83508C (es)
GR (1) GR852450B (es)
HU (1) HU199773B (es)
IL (1) IL76576A0 (es)
MC (1) MC1706A1 (es)
NO (1) NO161971C (es)
NZ (1) NZ213651A (es)
PH (1) PH23223A (es)
PT (1) PT81286B (es)
ZA (1) ZA857681B (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU573828B2 (en) * 1984-05-17 1988-06-23 E.R. Squibb & Sons, Inc. Tetrahydronaphthalenols
DE3630903A1 (de) * 1986-09-11 1988-03-24 Thomae Gmbh Dr K Neue tetrahydronaphthalin- und indanderivate, verfahren zu deren herstellung sowie diese enthaltende arzneimittel
CA1319144C (en) * 1986-11-14 1993-06-15 Quirico Branca Tetrahydronaphthalene derivatives
CA1329937C (en) * 1987-04-09 1994-05-31 Dennis Charles Thompson 1-phenyl-3-naphthalenyloxypropanamines
IT1224405B (it) * 1987-12-23 1990-10-04 Simes Composti attivi sul sistema cardiovascolare
DE3807813A1 (de) * 1988-03-10 1989-09-21 Thomae Gmbh Dr K Neue benzocycloheptenderivate, diese verbindungen enthaltende arzneimittel und verfahren zu deren herstellung
CA2011461A1 (en) * 1989-03-20 1990-09-20 Urs Hengartner Tetrahydronaphthalene derivatives
US5202486A (en) * 1990-07-31 1993-04-13 E. R. Squibb & Sons, Inc. Tetrahydroethanonaphthaleneamine derivatives
US5204373A (en) * 1991-08-26 1993-04-20 Bristol-Myers Squibb Company Farnesylated tetrahydro-naphthalenols as hypolipidemic agents
US5811557A (en) * 1997-04-30 1998-09-22 Roche Colorado Corporation Preparation of mibefradil via an acetonitrile anion
US5811556A (en) * 1997-04-30 1998-09-22 Roche Colorado Corporation Preparation of mibefradil via a naphthalenylacetic acid
US5808088A (en) * 1997-04-30 1998-09-15 Roche Colorado Corporation Preparation of mibefradil via an acetamide anion
WO2010046729A2 (en) * 2008-10-23 2010-04-29 Actelion Pharmaceuticals Ltd Tetrahydronaphthalene compounds
US8575361B2 (en) 2010-03-02 2013-11-05 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
US8513434B2 (en) 2010-03-02 2013-08-20 Concert Pharmaceuticals Inc. Tetrahydronaphthalene derivatives
WO2018152317A1 (en) * 2017-02-15 2018-08-23 Cavion, Inc. Calcium channel inhibitors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE913199C (de) * 1952-05-28 1954-06-10 Hartmann & Braun Ag Anzeigeinstrument zur Bestimmung von Polung und ungefaehrer Groesse des Strom- und Spannungsfehlers von Messwandlern in Verbindung mit Messwandler-Pruefeinrichtungen, die nach dem Differentialverfahren arbeiten
US3957845A (en) * 1962-04-27 1976-05-18 Knoll A.G. Chemische Fabriken Trifluoromethyl-substituted phenyl acetonitriles
GB1256753A (es) * 1969-05-30 1971-12-15
US4127588A (en) * 1976-10-01 1978-11-28 Hoffmann-La Roche Inc. Sulphur containing derivatives
JPS5896045A (ja) * 1981-11-30 1983-06-07 Sumitomo Chem Co Ltd 新規なジフエニルアルカノアミン誘導体およびその製造法

Also Published As

Publication number Publication date
EP0177960A3 (en) 1988-01-13
JPS6191157A (ja) 1986-05-09
US4680310A (en) 1987-07-14
PT81286B (pt) 1988-02-17
HU199773B (en) 1990-03-28
ES554020A0 (es) 1988-05-16
FI853817L (fi) 1986-04-12
CA1287636C (en) 1991-08-13
FI83508B (fi) 1991-04-15
GR852450B (es) 1986-02-11
ES8701145A1 (es) 1986-11-16
PT81286A (en) 1985-11-01
NO854036L (no) 1986-04-14
AU4830185A (en) 1986-04-17
KR860003200A (ko) 1986-05-21
ATE61791T1 (de) 1991-04-15
DE3582217D1 (de) 1991-04-25
EP0177960B1 (de) 1991-03-20
DK464885D0 (da) 1985-10-10
NO161971B (no) 1989-07-10
FI853817A0 (fi) 1985-10-02
FI83508C (fi) 1991-07-25
ES8802359A1 (es) 1988-05-16
CN85107496A (zh) 1986-07-23
NZ213651A (en) 1989-07-27
HUT38605A (en) 1986-06-30
ES547756A0 (es) 1986-11-16
MC1706A1 (fr) 1986-09-22
PH23223A (en) 1989-06-06
DK464885A (da) 1986-04-12
EP0177960A2 (de) 1986-04-16
ES8801174A1 (es) 1987-12-16
AU589375B2 (en) 1989-10-12
CN1007727B (zh) 1990-04-25
ZA857681B (en) 1986-05-28
NO161971C (no) 1989-10-18
IL76576A0 (en) 1986-02-28

Similar Documents

Publication Publication Date Title
ES554020A0 (es) Un procedimiento para la preparacion de derivados de tetrahidronaftaleno.
ES557359A0 (es) Un procedimiento para preparar derivados de piperazina
PT89122A (pt) Processo para a preparacao de tiazolidinodionas uteis como agentes hipoglicemicos e anti-aterosclerose
ES2053439T3 (es) Un procedimiento para la preparacion de un compuesto que tiene propiedades farmacologicas utiles.
ES2001794A6 (es) Un procedimiento para la preparacion de derivados de quinolina
PT81122B (pt) Processo para a preparacao de derivados de benzil-ftalazinona substituidos
FI844333L (fi) 11-substituerade 5h,11h-pyrrolo/2,1-c/ /1,4/benzoxazepiner, foerfarande foer deras framstaellning och deras anvaendning som laekemedel.
ES2033279T3 (es) Procedimiento para preparar un compuesto a base de quinolina.
ZA858659B (en) Use of spergualin derivatives for the preparation of medicaments having immunosuppressive activity
ES8708240A1 (es) Un procedimiento para la preparacion de nuevos compuestos poliprenilicos
ES2021515A6 (es) Procedimiento para la preparacion de compuestos derivados de isotiazolo-piridona azetidinil substituidos.
ES478323A1 (es) Un procedimiento para la preparacion de nuevos derivados de pirido 2,1-b quinazolina.
ES8609253A1 (es) Un procedimiento para la preparacion de derivados de dihi- dropiridina
SE8500822D0 (sv) Diazepinoindoles, their production and pharmaceutical compositions containing them
ES527308A0 (es) Procedimiento para la preparacion de derivados de benzazepina
ES2045335T3 (es) Un procedimiento para la preparacion de nuevas s-difluorometilhomocisteinas.
ES545870A0 (es) Procedimiento para preparar derivados de pirrolidindiona.
ATE79259T1 (de) Prophylaktische und heilende zusammensetzung enthaltende eine 8-chlorbenzothiazepin-verbindung und dessen verwendung.
ES546646A0 (es) Un procedimiento para preparar un compuesto relacionado con arfamenina
PT89356A (pt) Processo para a preparacao de derivados da 2-amino-tetra-hidro-isoquinolina e de composicoes farmaceuticas contendo os mesmos
ES2052812T3 (es) Un procedimiento para la preparacion de derivados de pirrolizina.
ES540693A0 (es) Un procedimiento de preparar sales quinato de alfa-2-piperi-dinil-2,8-bis(trifluorometil)-4-quinolino-metanol

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970401